| ACHIEVE LIFE SCIE. DL-001 |
| USA |
| Gesundheit |
| US0044685008 / A2QAR3 |
| SP4P (Frankfurt) / ACHV (NASDAQ) |
| FRA:SP4P, ETR:SP4P, SP4P:GR, NASDAQ:ACHV |
| - |
| https://achievelifescienc.. |
|
Achieve Life Sciences Inc. is a late-stage specialty pharmaceutical company dedicated to combating the global smoking health epidemic and nicotine addiction through the development and commercialization of cytisinicline. Cytisinicline is a plant-base..
>Volltext.. |
| 434.03 Mio. EUR |
| 421.65 Mio. EUR |
| - |
| -45.53 Mio. EUR |
| -45.32 Mio. EUR |
| -0.97 EUR |
| 13.03 Mio. EUR |
| 24.48 Mio. EUR |
| -39.5 Mio. EUR |
| 2.47 |
| - |
| -5.46% |
| - |
| - |
| - |
| - |
| ACHIEVE LIFE |
| 22.06.26 |
|
||||
|